<DOC>
	<DOCNO>NCT00028626</DOCNO>
	<brief_summary>RATIONALE : Embolization block blood flow part organ and/or tumor . Blocking portal vein one side liver may cause opposite side liver increase size decrease risk liver failure follow surgery . PURPOSE : Phase II trial study effectiveness portal vein embolization treat patient liver metastasis primary colorectal cancer .</brief_summary>
	<brief_title>Portal Vein Embolization Treating Patients With Liver Metastases From Primary Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether portal vein embolization result significant hypertrophy remain liver potentially decrease risk liver failure hepatic resection patient liver metastasis primary colorectal cancer . - Determine biologic effect therapy liver metastasis normal liver parenchyma patient . OUTLINE : Patients undergo portal vein embolization 200-300 micron polyvinyl chloride particle suspend Iohexol 300 . Approximately 3-6 week embolization , patient undergo exploratory laparotomy follow hepatic surgical resection . Patients follow least 6 month . PROJECTED ACCRUAL : A total 25 patient accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary colorectal adenocarcinoma metastasis liver consider hepatic resection Requirement removal least 60 % functional liver parenchyma base CT scan No extrahepatic disease laparoscopy PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : WBC least 2,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.8 mg/dL AST ALT great 80 IU/L Renal : Creatinine great 1.8 mg/dL Cardiovascular : No New York Heart Association class III IV heart disease Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 1 month since prior systemic chemotherapy Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics Other : At least 2 month since prior investigational treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>liver metastasis</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
</DOC>